Literature DB >> 28029311

Overestimated Value of Baseline Total Metabolic Tumor Volume at 18F-Labeled Fluorodeoxyglucose Positron Emission Tomography in Follicular Lymphoma.

Hugo J A Adams1, Thomas C Kwee1.   

Abstract

Entities:  

Year:  2016        PMID: 28029311     DOI: 10.1200/JCO.2016.70.4890

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL.

Authors:  Chelsea C Pinnix; Andrea K Ng; Bouthaina S Dabaja; Sarah A Milgrom; Jillian R Gunther; C David Fuller; Grace L Smith; Zeinab Abou Yehia; Wei Qiao; Christine F Wogan; Mani Akhtari; Osama Mawlawi; L Jeffrey Medeiros; Hubert H Chuang; William Martin-Doyle; Philippe Armand; Ann S LaCasce; Yasuhiro Oki; Michelle Fanale; Jason Westin; Sattva Neelapu; Loretta Nastoupil
Journal:  Blood Adv       Date:  2018-06-12

2.  Prognostic values of baseline, interim and end-of therapy 18F-FDG PET/CT in patients with follicular lymphoma.

Authors:  Yeye Zhou; Zixuan Zhao; Yiwei Wu; Jihui Li; Bin Zhang; Shibiao Sang; Shengming Deng
Journal:  Cancer Manag Res       Date:  2019-07-23       Impact factor: 3.602

3.  Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma.

Authors:  Tzu-Hua Chen-Liang; Taida Martín-Santos; Andrés Jerez; Guillermo Rodríguez-García; Leonor Senent; Cristina Martínez-Millán; Begoña Muiña; Mayte Orero; Anabel Teruel; Alejandro Martín; Joaquín Gómez-Espuch; Kyra Kennedy; Carmen Benet; José María Raya; Marta Fernández-González; Fátima de la Cruz; Marta Guinot; Carolina Villegas; Isabel Ballester; Mónica Baile; María Moya; Javier López-Jiménez; Laura Frutos; José Luis Navarro; Jon Uña; Rosa Fernández-López; Carolina Igua; José Contreras; Raquel Sánchez-Vañó; María Del Puig Cozar; Pilar Tamayo; Jorge Mucientes; José Javier Sánchez-Blanco; Elena Pérez-Ceballos; Francisco José Ortuño
Journal:  Cancer Med       Date:  2017-09-27       Impact factor: 4.452

4.  Cerebellum/liver index in pretherapeutic 18F-FDG PET/CT as a predictive marker of progression-free survival in follicular lymphoma treated by immunochemotherapy and rituximab maintenance.

Authors:  François Godard; Eric Durot; Carole Durot; Christine Hoeffel; Alain Delmer; David Morland
Journal:  Medicine (Baltimore)       Date:  2022-02-04       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.